Calciphylaxis is a rare disorder in pati ents with chronic renal failure that is characterized by ischemic necrotic skin lesions. The pro gnosis is grave and mortality is high (80%). The precise mechanism of calciphylaxis is still unknown, but in addition to chronic renal failu re, elevated parath yroid hormone levels appear to playa role. . The role of parathyroidectomy in treating affected patients is questionable. In this article, we describ e the case of a patient with chronic renal fa ilure who developed rapidly progressiv e subcutaneous calcifications and ulcerations in the lower extremities. These lesions regressed fo llowin g subtotal parathyroidectomy . We also review the literature on calciphylaxis, with a f ocus on treatment options.
tion ." Calciphylaxis can also occur in predialysis patients and in otherwise healthy kidney transplant recipients." The highest risk of calciphyl axis is see n in long-term hemodial ysis patients who have high levels of parathyroid hormo ne (PTH) (» I,000 pg/ml )." Females are affected more than male s (ratio: 3 to 1).s,1O Altho ugh the mean age of affected patient s is 48 years, .the reported age spectrum is wide, ranging from 6 months to 83 years. I The clinic al features of calciphyl axis are primari ly cutaneou s. In the early phase of the disorder, dermatologic features can include purpuric patches and plaques in a reticulate pattern with focal centr al necros is. Late skin manifestatio ns include dusky plaques with woody induration, which can evo lve into irregular ulcers covered by thick, dark eschars that are exquisitely tender and lead to necrosis of the subcutaneous fat. Extracut aneous manifestations are rarely reported. Lesions primarily involve the proxi mal part of the lower extremities and trunk (44 to 68% of cases); the abdomen and penis have been repor ted to be involved, as well.!':" Digital gangrene some times occurs.P:"
Histopathologic exam ination reveals the presence of calcium deposits in the wall of the small-to-medium blood vessels of the derm is and subcutaneous fat ; the development of these deposits is follow ed by fibrob last .proliferation and giant-cell formation. IS As a result , fibrosis, intimal hyperpl asia, and occas ionally thrombosis of the vessels occur, followed by ischemic necro sis of the skin."
The differential diagnosis of calciph ylaxis include s antiphospholipid-an tibody syndrome, warfarin-induced skin necrosis, purpu ra fulminans, microembolization, pyoderm a gangrenosum, and necro tizing fasciitis."
The mechanism responsible for the hyperca lcinosis involves the meta bolism of calci um, phosphor us, vitamin D, and PTH in the presence of long-standing end-stage ENT-Ear , Nose & Throat Journal· May 2003 . renal failure. The kidney dysfunction leads to decreased hydroxylation of 1,25-dihydroxyvitamin D 3 , inadequate synthesis of biologically active vitamin D, hypocalcemia caused by diminished calcium absorption from the intestine , and secondary hyperparathyroidism. In advanced stages, autonomous parathyroid gland secretion might develop and cause tertiary hyperparathyroidism. The end points of the process are elevated calcium and phosphorus levels .'>"
The pathogenesis of calciphylaxis was first described in detail by Selye in 1962. 17 • 18 He found that iron , inorganic salt , or glucocorticoid challenge in vitamin D-or PTH c sensitized rats led to the development of varying degrees of inflammation, calcinosis, and sclerosis in the skin and in virtually all organs examined. Selye concluded that unlike the case with simple metastatic calcifications, this response occurred only with the use of a sensitizer and a challenger. 17 In humans, the high serum PTH levels act as the sensitizer, but the identity of the challenger remains unknown. Trauma, albumin, warfarin, and steroids have all been suggested.v" The pathogenesis is still not entirely clear because not every case of hyperparathyroidism involves calciphylaxis.
Because no feature is pathognomonic for calciphylaxis, the diagnosis must be based on a combination of the clinical history, physical examination, and histopathologic findings on skin biopsy along with the typical finding of "pipestem" vessels on radiologic studies."
Mortality is high (80%), and death is usually attributable to infection of the skin lesions in immunocompromised patients. 1 The location of disease manifestations is an important prognostic factor; when the disease is confined to the distal extremities, the prognosis is better. 1 Chan et al reported that patients whose disease involves the toes distal to the midcalfhave a more favorable prognosis than do patients whose disease involves the trunk, shoulder, buttocks, and thighs ." In their review of the literature, Hafner et al found that 40 of 53 patients (75.5 %) with distal localization necrosis survived their skin complications (all skin lesions had healed); the remaining patients died of thei r disease 6 weeks to 21 months following the onset of uremic small-artery disease, most as a result of complications. I In that study, only 11 of 42 patients (26.2 %) who exhibited a proximal pattern survived. Leukocytosis exceeding 20,000 cells/ml predicts a worse outcome. " Age , dialysis, and kidney transplantation do not have any prognostic value.
In view of the grave prognosis of patients with calciphylaxis, a wide variety of treatment modalities has been tried, all with limited success. In this article, we describe the case of a patient with calciphylaxis in whom subtotal parathyroidectomy effectively alleviated all signs and symptoms. We also review the literature and discuss other therapies, as well. 
Case report
A 56-year-old man with a 6-year history of dialysisdependent chronic renal failure secondary to streptococcal glomerulonephritis was admitted to our center with a 4-month history of induration of both thighs that had become painful 1 week earlier. His medical history was significant for chronic obstructive pulmonary disease, blindness of unknown cause, paroxysmal atrial fibrillation, ischemic heart disease, congestive heart failure, and hepatitis B virus infection. He also had a history of repeated hospitalizations for pneumonia as well as the atrial fibrillation . The patient was taking vitamin D, a calcium supplement, and a beta blocker.
On physical examination, the patient was pale and exhibited edema of both legs . An erythematous livedo reticularis rash was noted on both thighs. Palpation of the thighs revealed the presence of hard and painful subcutaneous nodules covered with puerperal erythema and two ulcerative areas with round, sharp edges (figure 1). Ultrasonography detected splenomegaly and calcifications of the large vessels around the subcutaneous calcifications. No other significant finding was recorded.
Laboratory studies revealed that the patient's serum PTH level ranged between 325 and 1,540 pg/dl. His erythrocyte sedimentation rate was 40 mm/hr, and his white blood cell count was 12,300/mm 3 • Serum values were as follows: calcium, 9.3 mg/dl; phosphorus, 6.0 mg/ dl; albumin, 3 g/dl; urea, 105 mg/dl; creatinine, 6.57 mg/ dl; and fasting total proteins, 7.9 g/dl. His liver enzyme and proteins C and S values were within normal limits. Cultures of his skin lesions were positive for coagulasepositive, methicillin-resistant, fucidic-acid-sensiti ve staphylococcus.
Microscopic analysis of the cutaneous lesion sections revealed the presence of widespread ulceration and necro-dressings, a low-calcium and low-phosphorus diet, phosphate-binding agents , antibiotics, and dialysis have all been tried with various degrees of success." Hyperbaric oxygen therapies have also been reported to be benefi-ciaJ. 21.22 Parathyroidectomy would appear to be an important treatment beca use it removes the presumed sensitizing agent (PTH) as well as the stimu lus for hypercalcemia, which is believed to play an important etiologic role .PThe firs t successful use of subtotal parathyroidectomy in a patient with vascular calcification and skin necrosis was described in 1970 by Massry et aU 3 In 1976, Gipstein et al suggested that total or subtotal parathyroidectomy be considered for the treatment of ischemic skin lesions in uremic patients and in renal transplant recipients." Autotransplantation or cryopreservation of removed parathyroid tissue is routine when total parathyroidectomy is chosen as the mode of treatment. After our patient underwent subtotal parathyroidectomy , his calcium level returned to normal.
The two main complications of parathyroidectomy in patients with calciphylaxis are infections of the incision" and recurrent hyperparathyroidism with nonregressive cutaneous lesions.' Neither of these complications occurre d in our patient. In terms of survival, Hafner et al demonstrated the advantage of parathyroidectomy in 104 cases of calciphylaxis.' In their study, two -thirds ofthe 58 patients who underwent surgery survived, compared with only one-third of those who did not undergo surgery. In sis in both the skin and subcutaneous fat. The media of mediumsized blood vessels contained heavy deposits of calcium (figure 2 ) . In addition, some of these vessels were occluded by organizing thrombi . Mic rocalcifications were also present freely within the necrotic tissues, and they were accompanied by a foreign-body reaction. The histologic findings were consistent with both metastatic and dystrophic calcifications, and overa ll they were typical of calc iphylaxis.
The patient was treated with antibiotics and vitamin D, but he showed no improvement. Ultrasonography of the parathyroids and sestamibi scanning detected no evidence of parathyroid enlargement. Because of the rapid progression of the cutaneous lesions and associated aseptic necrosis, exploration of the neck via subtotal parathyroidectomy was performed. Three-and -one-half glands were removed, leaving only one-half of the left inferior parathyroid gland. All of the glands were larger and heavier than average; their size ranged from 0.6 to 1.5 em and their weight from 0.24 to 0.29 g.
The parathyroid tis sue submitted for examination was markedly hypercellular and did not contain a rim of residual normal parathyroid tissue ( figure 3) . The hypercellular gland was predominantly made up of chief cells and a small number of clear and oncocytic cells . These features were consistent with secondary parathyroid hyperplasia-a diagnosis that was supported by the patient's clinical history of chronic renal failure.
After surgery, the patient's serum PTH level dropped to 188 pg/dl. His serum calcium level was maintained at 7.8 to 7.9 mg/d l with calcium and vitamin D supp lements. His phosphorus leve l ranged from 4.1 to 6.6 mg/dl and his albumin level from 2.8 to 3.1 g/dl. The improvement in his skin lesions was dramatic. The skin incisions hea led rapidly, and the necrotic lesions regressed. The patient later underwent skin transplantation, and the repair was almost complete..He was discharged after 5 weeks.
Discussion
Because the pathogenesis of calciphylaxis and its relationship to high levels of PTH are not completely understood, the need for parathyroidectomy in affected patients is still controversial. 1,3,12 Nonsurgical trea tment with wet contrast, Chan et al reviewed 47 cases of calciph ylaxis and concluded that parathyroidectomy was not associated with any statistically significant survival advantage." Likewise, Roe et al also failed to note any dramatic advantage to surger y, as only two of their seven patients experienced any benefit from itY
The role of parathyroidectomy for calciphylaxis is particularly questionable in patients whose serum calcium and PTH levels are norm al. Kane et al claimed that parathyroidectomy should not be performed in the absence of document ed hyperparathyroidi sm becau se it would result in low-turnover bone disease, which would eventually elevate calcium and phosphorus levels and promot e furth er calciphylaxis.'
Because remo val of the parath yroid glands does not always result in a resolution of the clinical condition, several authors have conclud ed that the primary factor s associated with surgical succes s are (1) the amount of time that has elapsed between diagnosis and surgic al intervention, (2) the patient 's general health status, and (3) the location, number, and severity of the skin lesions: I ,3, 12, 13 On the basis of our experience and that of others who have reported a rapid regression of calciphyl actic skin lesions follo wing parathy roidectomy, we suggest that this procedure is a potenti ally important modality for the treatment of this life-th reatening condition, and we recommend that it be considered for every calciphylaxis patient. Furth er studies are needed to elucidate the pathogenesis of the disorder and the optimal treatment mod ality.
